Rockwell Medical Inc (NASDAQ:RMTI) insider David S. Richmond acquired 5,869 shares of the stock in a transaction on Wednesday, March 27th. The shares were bought at an average cost of $5.59 per share, for a total transaction of $32,807.71. Following the purchase, the insider now directly owns 177,930 shares of the company’s stock, valued at approximately $994,628.70. The acquisition was disclosed in a filing with the SEC, which is accessible through the SEC website.
Shares of Rockwell Medical stock remained flat at $$4.75 during trading hours on Friday. The stock had a trading volume of 171,391 shares, compared to its average volume of 285,652. Rockwell Medical Inc has a twelve month low of $2.19 and a twelve month high of $6.88. The firm has a market cap of $271.22 million, a price-to-earnings ratio of -10.11 and a beta of 2.12.
Rockwell Medical (NASDAQ:RMTI) last announced its quarterly earnings results on Thursday, March 14th. The company reported ($0.15) EPS for the quarter, missing the Thomson Reuters’ consensus estimate of ($0.13) by ($0.02). Rockwell Medical had a negative net margin of 52.23% and a negative return on equity of 121.54%. The business had revenue of $16.85 million during the quarter, compared to analyst estimates of $16.10 million. On average, research analysts forecast that Rockwell Medical Inc will post -0.61 earnings per share for the current year.
A number of equities analysts have weighed in on the company. ValuEngine lowered Rockwell Medical from a “buy” rating to a “hold” rating in a research note on Wednesday, April 10th. Ifs Securities raised Rockwell Medical from an “outperform” rating to a “strong-buy” rating in a research note on Monday, March 18th.
COPYRIGHT VIOLATION NOTICE: This report was first posted by Baseball Daily News and is the property of of Baseball Daily News. If you are accessing this report on another publication, it was copied illegally and reposted in violation of U.S. & international copyright and trademark laws. The legal version of this report can be read at https://www.baseballdailydigest.com/news/2019/04/21/rockwell-medical-inc-rmti-insider-david-s-richmond-acquires-5869-shares-of-stock.html.
Rockwell Medical Company Profile
Rockwell Medical, Inc operates as an integrated biopharmaceutical company targeting end-stage renal and chronic kidney diseases in the United States and internationally. The company's lead drug includes Triferic, an iron maintenance therapy that replaces the iron lost by patients during hemodialysis treatment.
Receive News & Ratings for Rockwell Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Rockwell Medical and related companies with MarketBeat.com's FREE daily email newsletter.